Shah Pritesh 4
4 · NovoCure Ltd · Filed Jan 9, 2023
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Shah Pritesh
Chief Commercial Officer
Transactions
- Sale
Ordinary Shares
2023-01-05$108.00/sh−387$41,796→ 82,843 total
Footnotes (1)
- [F1]Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah.